0001179110-11-011696.txt : 20110803 0001179110-11-011696.hdr.sgml : 20110803 20110803182605 ACCESSION NUMBER: 0001179110-11-011696 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110801 FILED AS OF DATE: 20110803 DATE AS OF CHANGE: 20110803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alton Gregg H CENTRAL INDEX KEY: 0001334682 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 111008115 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgar.xml FORM 4 - X0304 4 2011-08-01 0 0000882095 GILEAD SCIENCES INC GILD 0001334682 Alton Gregg H GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 0 1 0 0 EVP, Corp & Med Affairs Common Stock 2011-08-01 4 M 0 12000 16.01 A 44790 D Common Stock 2011-08-01 4 S 0 11000 41.5968 D 33790 D Common Stock 2011-08-01 4 S 0 2000 42.5730 D 31790 D Non-Qualified Stock Option (right to buy) 16.01 2011-08-01 4 M 0 12000 0 D 2015-01-26 Common Stock 12000 27500 D The options have a 5 year vesting schedule. 20% of the options vested on January 26, 2006, the first anniversary of the date of the grant. The balance vested 5% every three months thereafter until fully vested on January 26, 2010. The options expire on January 26, 2015. Sale prices reported for the transactions reported here range from $41.30 to $42.21. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $42.57 to $42.58. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request. Amount of securities beneficially owned includes 577 shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan on June 30, 2010. The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 105b-1 trading plan established by Mr. Alton on August 19, 2009 and amended July 30, 2010. /s/Gregg H. Alton 2011-08-03